Close Menu

NEW YORK (GenomeWeb) – The US Food and Drug Administration today approved Qiagen's therascreen EGRF test as a companion diagnostic test for AstraZeneca's Iressa (gefitinib) for the first-line treatment of patients with metastatic non-small lung cancer. 

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.

Dec
02

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.